5 résultats
FIELD OF INDUSTRIAL UTILITY
This invention relates to novel proteins useful as vaccines and a method of producing the same.
BACKGROUND ART
Type B hepatitis is a viral disease which occurs frequently in particular in the tropics of Africa, in Southeast Asia and in the Far East. Hepatitis B is
FIELD OF INDUSTRIAL UTILITY
This invention relates to novel proteins useful as vaccines and a method of producing the same.
BACKGROUND ART
Type B hepatitis is a viral disease which occurs frequently in particular in the tropics of Africa, in Southeast Asia and in the Far East. Hepatitis B is
BACKGROUND OF THE INVENTION
1. Field of Invention
This invention relates to serine protease inhibitor Kazal (SPIK/SPINK/PSTI) and more specifically, its inhibitors and the use of inhibitors of SPIK as anti-cancer agents and anti-viral agents such as hepatitis B and C virus (HBV and HCV).
2.
FIELD
This disclosure relates to the field of viral vectors, specifically to a live, attenuated rubella viral vector platform capable of expressing a heterologous antigen, and the use of this platform to induce an immune response.
BACKGROUND
The worldwide spread of human immunodeficiency
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase of International Patent Application No. PCT/RU2016/000197, filed on Apr. 6, 2016, which published as WO 2016/159836 A1 on Oct. 6, 2016, and claims priority to Russian Patent Application No. 2015113254, filed on Apr. 3,